Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Oncogene

• Publication date

  2002-10-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1205853PMID 12360407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells

  2002cited by this paper
• Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an approximately 700 kDa Apaf-1 containing apoptosome complex.

  2001cited by this paper
• TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2

  2001cited by this paper
• Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an ∼700 kDa Apaf-1 containing apoptosome complex

  2001influential reference
• Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling Complex*

  2001influential reference
• Modulation of Tumor Necrosis Factor Apoptosis-inducing Ligand- induced NF-κB Activation by Inhibition of Apical Caspases*

  2001cited by this paper
• Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

  2001cited by this paper
• Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide.

  2000cited by this paper
• FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.

  2000cited by this paper
• TRAIL receptor-2 signals apoptosis through FADD and caspase-8

  2000cited by this paper
• Active Caspases and Cleaved Cytokeratins Are Sequestered into Cytoplasmic Inclusions in Trail-Induced Apoptosis

  2000cited by this paper
• Regulation of the Fas Death Pathway by FLICE-Inhibitory Protein in Primary Human B Cells1

  2000cited by this paper
• Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.

  2000cited by this paper
• Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

  2000cited by this paper
• Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

  2000cited by this paper
• TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention

  2000cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.

  2000cited by this paper
• Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.

  2000cited by this paper
• Failure of Bcl‐2 to block cytochrome c redistribution during TRAIL‐induced apoptosis

  2000cited by this paper
• TCR-Mediated Up-Regulation of c-FLIPshort Correlates with Resistance Toward CD95-Mediated Apoptosis by Blocking Death-Inducing Signaling Complex Activity1

  2000cited by this paper
• Molecular determinants of response to TRAIL in killing of normal and cancer cells.

  2000cited by this paper
• Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• IAP family proteins--suppressors of apoptosis.

  1999cited by this paper
• The Role of c-FLIP in Modulation of CD95-induced Apoptosis*

  1999influential reference
• Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

  1999cited by this paper
• Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

  1999cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer

  1999cited by this paper
• Prevention of constitutive TNF receptor 1 signaling by silencer of death domains.

  1999cited by this paper
• Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases

  1999cited by this paper
• Distinct Caspase Cascades Are Initiated in Receptor-mediated and Chemical-induced Apoptosis*

  1999cited by this paper
• Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells

  1998influential reference
• NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

  1998cited by this paper
• FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis.

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.

  1998cited by this paper
• Rare loss-of-function mutation of a death receptor gene in head and neck cancer.

  1998cited by this paper
• Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.

  1998cited by this paper
• Cell death attenuation by `Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex

  1998cited by this paper
• FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b*

  1997cited by this paper
• Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis

  1997cited by this paper
• Role of the CD40 and CD95 (APO‐1/Fas) antigens in the apoptosis of human B‐cell malignancies

  1997cited by this paper
• Activity of TNF‐related apoptosis‐inducing ligand (TRAIL) in haematological malignancies

  1997cited by this paper
• Inhibition of death receptor signals by cellular FLIP

  1997influential reference
• Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death.

  1996cited by this paper
• Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA.

  1996cited by this paper
• A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis

  1996cited by this paper
• FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.

  1996cited by this paper
• FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

  1995cited by this paper
• Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.

  1995cited by this paper
• Chronic lymphocytic leukemia.

  1995cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• Inability of a human lung tumour cell line (A549) to detect chemically induced organ-specific toxicity to the lung.

  1987cited by this paper

• TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling

  2024cites this paper
• The Identification of New c-FLIP Inhibitors for Restoring Apoptosis in TRAIL-Resistant Cancer Cells

  2024cites this paper
• Cellular stress management by caspases.

  2024cites this paper
• EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory protein

  2024cites this paper
• HDAC inhibitors: Promising agents for leukemia treatment.

  2023cites this paper
• Genetic variations in tumor necrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt

  2021cites this paper
• The ClpP activator ONC‐212 (TR‐31) inhibits BCL2 and B‐cell receptor signaling in CLL

  2021cites this paper
• Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia

  2021cites this paper
• Targeting apoptotic caspases in cancer.

  2020cites this paper
• The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma

  2019cites this paper
• The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia.

  2018cites this paper
• TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia.

  2018cites this paper
• Antihypertensive drug‐candesartan attenuates TRAIL resistance in human lung cancer via AMPK‐mediated inhibition of autophagy flux

  2018cites this paper
• Sensitization of recombinant human tumor necrosis factor-related apoptosis-inducing ligand-resistant malignant melanomas by quercetin

  2018cites this paper
• Cancer RNome: Evolution and Sustenance

  2018cites this paper
• Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis

  2017cites this paper
• Identification and Characterisation of Novel Mechanisms that Regulate TRAIL-Receptor Signalling Complexes

  2017influential citation
• Therapeutic Potential of rhTRAIL for Malignant Melanoma

  2017cites this paper
• Trichothecenes: immunomodulatory effects, mechanisms, and anti-cancer potential

  2017cites this paper
• Identification of Novel Epitopes with Agonistic Activity for the Development of Tumor Immunotherapy Targeting TRAIL-R1

  2017influential citation
• Metabolic status modulates tumour cell sensitivity to apoptotic stimuli

  2016influential citation
• Developing an in vitro co-culture model to investigate the role of TRAIL in lung inflammation

  2016cites this paper
• TRAIL and targeting cancer cells: between promises and obstacles.

  2015cites this paper
• Genetic association between TRAIL-R1 Thr209Arg and cancer susceptibility

  2015cites this paper
• Biochemical Analysis of Initiator Caspase-Activating Complexes: The Apoptosome and the Death-Inducing Signaling Complex.

  2015cites this paper
• Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein

  2015cites this paper
• Activation, Isolation, and Analysis of the Death-Inducing Signaling Complex.

  2015cites this paper
• Immune evasion strategies of molluscum contagiosum virus.

  2015cites this paper
• Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.

  2015cites this paper
• Beta-Sitosterol: A Promising but Orphan Nutraceutical to Fight Against Cancer

  2015cites this paper
• Targeting death receptors for TRAIL by agents designed by Mother Nature.

  2014cites this paper
• Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.

  2014cites this paper
• c-FLIPp43 induces activation of the nuclear factor‑κB signaling pathway in a dose-dependent manner in the A375 melanoma cell line.

  2014cites this paper
• The role of inflammation in leukaemia.

  2014cites this paper
• Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia.

  2014cites this paper
• Phase II trial of mapatumumab, a fully human agonist monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1), in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

  2014cites this paper
• Roles of ligands from the TNF superfamily in B cell development, function, and regulation.

  2014cites this paper
• Targeting c-FLIP in cancer.

  2013cites this paper
• Plasma protein analysis of patients with different B‐cell lymphomas using high‐content antibody microarrays

  2013cites this paper
• Tumor Resistance to Antibody-Mediated Immunotherapy and Reversal of Resistance: Rituximab as Prototype

  2013cites this paper
• B-cell chronic lymphocytic leukemia (B-CLL) cells The natural product Honokiol induces caspase-dependent apoptosis in

  2013cites this paper
• Precision medicines for B‐cell leukaemias and lymphomas; progress and potential pitfalls

  2013cites this paper
• c-FLIP does not correlate with response to immunochemotherapy treatment and outcome of patients with nodal diffuse large B-cell lymphoma.

  2013cites this paper
• Isolation, characterisation and reconstitution of cell death signalling complexes.

  2013cites this paper
• Multiparameter flow cytometric immunophenotyping of epithelial cells in effusions. Technical improvements and apoptosis measurement.

  2013cites this paper
• Targeting apoptosis proteins in hematological malignancies.

  2013cites this paper
• The three Rs along the TRAIL: Resistance, re-sensitization and reactive oxygen species (ROS)

  2012cites this paper
• THE HISTONE DEACETYLASE INHIBITOR, MS-275, SENSITIZES METASTATIC OSTEOSARCOMA TO FASL-INDUCED CELL DEATH: A ROLE FOR C-FLIP

  2012cites this paper
• The Molecular Mechanisms of 5-Fluorouracil-Induced Apoptosis in Human Colorectal Cancer Cells and the Use of 5-FU as a Sensitising Agent to TRAIL

  2012cites this paper
• The Identification and Characterisation of Novel Proteins and Metabolic Signalling Pathways that Regulate TRAIL-Induced Apoptosis

  2012cites this paper
• Glucose—a sweet way to die

  2012cites this paper
• The Transcription Factor Wilms Tumor 1 Confers Resistance in Myeloid Leukemia Cells against the Proapoptotic Therapeutic Agent TRAIL (Tumor Necrosis Factor α-related Apoptosis-inducing Ligand) by Regulating the Antiapoptotic Protein Bcl-xL*

  2012cites this paper
• Regulation of autophagy in hematological malignancies: role of reactive oxygen species

  2012cites this paper
• Advocating the need of a systems biology approach for personalised prognosis and treatment of B-CLL patients

  2012cites this paper
• Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia

  2012cites this paper
• A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death

  2012cites this paper
• Tumor Necrosis Factor (TNF) Receptor-associated Factor 7 Is Required for TNFα-induced Jun NH2-terminal Kinase Activation and Promotes Cell Death by Regulating Polyubiquitination and Lysosomal Degradation of c-FLIP Protein*

  2012cites this paper
• The microenvironment and treatment resistance in chronic lymphocytic leukemia

  2012cites this paper
• 2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression

  2011cites this paper
• Phytochemical metabolites and their effects on in vitro and in vivo measures of oxidative stress

  2011cites this paper
• Flow cytometric measurement of cellular FLICE‐inhibitory protein (c‐FLIP) in ovarian carcinoma effusions

  2011cites this paper
• Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL

  2011cites this paper
• Distinct TRAIL resistance mechanisms can be overcome by proteasome inhibition but not generally by synergizing agents.

  2011cites this paper
• In vivo and in vitro studies of immunodeficiency in Ataxia-telangiectasia

  2011influential citation
• Signalling Pathways Leading to TRAIL Resistance

  2011influential citation
• Novel X‐linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL‐mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis

  2011cites this paper
• Plumbagin treatment leads to apoptosis in human K562 leukemia cells through increased ROS and elevated TRAIL receptor expression.

  2011cites this paper
• The therapeutic potential of TRAIL receptor signalling in cancer cells

  2011cites this paper
• 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF MESALAMINE, SENSITIZES COLON CANCER CELLS TO TRAIL-INDUCED APOPTOSIS BY REGULATING DEATH RECEPTOR 5 AND SURVIVIN EXPRESSION.

  2011cites this paper
• Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses

  2011cites this paper
• Targeted treatment for chronic lymphocytic leukemia

  2011cites this paper
• A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells

  2011cites this paper
• CFLAR (CASP8 and FADD-like apoptosis regulator)

  2011cites this paper
• Estudio de los mecanismos que regulan la expresión y función del ligando de muerte TRAIL en células T normales y leucémicas

  2011cites this paper
• Nimbolide Sensitizes Human Colon Cancer Cells to TRAIL through Reactive Oxygen Species- and ERK-dependent Up-regulation of Death Receptors, p53, and Bax*

  2010cites this paper
• Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL.

  2010cites this paper
• The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo

  2010cites this paper
• Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect

  2010cites this paper
• Papel fundamental de cFLIP en el control de la apoptosis en células epiteliales de mama

  2010cites this paper
• Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells

  2010cites this paper
• Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist

  2010cites this paper
• Proteomic and molecular characterisation of TRAIL-induced signalling complexes

  2010cites this paper
• Cell death targeting therapies in B lymphoid malignancies.

  2010cites this paper
• Exploring death receptor pathways as selective targets in cancer therapy.

  2010cites this paper
• In vivo Untersuchungen zur Wirksamkeit des agonistischen TRAIL-Rezeptorantikörpers HGS-ETR-2 (Lexatumumab) in Kombination mit ionisierender Strahlung im Nacktmausmodell mit einem Coloncarcinom-Xenograftsystem

  2010influential citation
• Apoptosis in leukemias: regulation and therapeutic targeting.

  2010cites this paper
• Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells.

  2010cites this paper
• Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy

  2010cites this paper
• Signalling to drug resistance in CLL.

  2010cites this paper
• TRAIL-Rezeptor-Agonisten, eine neue Klasse proapoptotischer Krebstherapeutika

  2010cites this paper
• TRAILing death in cancer.

  2010cites this paper
• Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL

  2010cites this paper
• TRAIL/TRAIL‐R in hematologic malignancies

  2010influential citation
• Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines.

  2010cites this paper
• HDAC inhibitors with different gene regulation activities depend on the mitochondrial pathway for the sensitization of leukemic T cells to TRAIL-induced apoptosis.

  2010cites this paper
• Improving the response to molecular targeting of the TRAIL death receptors in colon cancer cells

  2010influential citation
• Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients

  2010cites this paper
• Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis

  2010cites this paper
• NF-κB as a therapeutic target in chronic lymphocytic leukemia

  2010cites this paper
• AMPK-independent down-regulation of cFLIP and sensitization to TRAIL-induced apoptosis by AMPK activators.

  2010cites this paper